Although there is a report with the application using HGF gene therapy on a rat model of NAFLD-fibrosis (15), to the best of our knowledge, the therapeutic effect of recombinant HGF protein on the development of NASH has not been reported. Here, HGF is linked to metabolic dysfunction-associated steatohepatitis.